In addition, molecular profiling has identified genetic NHL signatures which predict poor prognoses e.g., double-hit lymphomas displaying aberrant expression of Bcl-2, c-Myc, and/or Bcl-6 [2]. The gene discussed is MYC; the disease is non-Hodgkin lymphoma.